PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA.\', \'School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA.\', \'Department of Biochemistry, University of Wisconsin, Madison, WI, USA.\', \'Cryo-EM Research Center, Department of Biochemistry, University of Wisconsin, Madison, WI, USA.\', \'Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA. yoshihiro.kawaoka@wisc.edu.\', \'Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan. yoshihiro.kawaoka@wisc.edu.\', \'School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA. ravi.kane@chbe.gatech.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s42003-021-02128-8
?:hasPublicationType
?:journal
  • Communications biology
is ?:pmid of
?:pmid
?:pmid
  • 34011948
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all